Safety and Efficacy of Different Administration Sequences of L19TNF With Lomustine in Glioblastoma at First Progression

NCT05304663 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped The Sponsor had no further plan for the study in object

Conditions

Glioblastoma

Interventions

DRUG: Onfekafusp alfa
DRUG: Lomustine

Sponsor

Philogen S.p.A.